T. Rowe Price Associates’s United States Antimony UAMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$72.8M Buy
10,031,734
+9,947,422
+11,798% +$90M 0.01% 775
2026
Q1
$737K Buy
84,312
+21,227
+34% +$185K ﹤0.01% 2283
2025
Q4
$317K Buy
63,085
+14,351
+29% +$113K ﹤0.01% 2619
2025
Q3
$303K Buy
48,734
+2,770
+6% +$11.6K ﹤0.01% 2600
2025
Q2
$101K Buy
+45,964
New +$130K ﹤0.01% 2889

Other funds holding UAMY

T. Rowe Price Associates's UAMY Position: Q2 2026 in Review

T. Rowe Price Associates increased its United States Antimony (UAMY) stake by 11,798% in Q2 2026, buying an estimated $90M and bringing the position to 10,031,734 shares worth $72.8M. The position accounts for 0.01% of the portfolio, ranked #775.

T. Rowe Price Associates first reported a position in UAMY in Q2 2025 and has held it in 5 quarters since. 240 funds tracked by Wall St. Rank hold UAMY as of Q2 2026.

  • T. Rowe Price Associates held 10,031,734 shares of United States Antimony worth $72.8M as of Q2 2026.
  • T. Rowe Price Associates bought 9,947,422 United States Antimony shares in Q2 2026, an estimated $90M.
  • United States Antimony made up 0.01% of T. Rowe Price Associates's portfolio in Q2 2026, its #775 holding.
  • T. Rowe Price Associates first reported a position in United States Antimony in Q2 2025 and has held it in 5 quarters since.
  • 240 funds tracked by Wall St. Rank held United States Antimony as of Q2 2026.

Based on T. Rowe Price Associates's 13F filing for Q2 2026, filed 14 Aug 2026.